Saumya Sutaria - Mar 6, 2023 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Role
CEO, Director
Signature
Chad J. Wiener, as Attorney-in-Fact for Saumya Sutaria
Stock symbol
THC
Transactions as of
Mar 6, 2023
Transactions value $
-$4,475,109
Form type
4
Date filed
3/7/2023, 08:32 PM
Previous filing
Mar 3, 2023
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THC Common Stock Options Exercise +21.1K +6.51% 344K Mar 6, 2023 Direct F1, F2
transaction THC Common Stock Tax liability -$633K -10.4K -3.03% $60.62 334K Mar 6, 2023 Direct F3, F4
transaction THC Common Stock Options Exercise +25.2K +7.55% 359K Mar 6, 2023 Direct F2, F5
transaction THC Common Stock Tax liability -$742K -12.5K -3.48% $59.29 347K Mar 6, 2023 Direct F3, F4
transaction THC Common Stock Options Exercise +48K +13.83% 395K Mar 6, 2023 Direct F2, F6
transaction THC Common Stock Tax liability -$1.41M -23.8K -6.03% $59.29 371K Mar 6, 2023 Direct F3, F4
transaction THC Common Stock Options Exercise +57.4K +15.49% 428K Mar 6, 2023 Direct F2, F7
transaction THC Common Stock Tax liability -$1.69M -28.5K -6.66% $59.29 400K Mar 6, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THC 2022 February Restricted Stock Units Options Exercise $0 -21.1K -33.33% $0.00 42.1K Mar 6, 2023 Common Stock 21.1K Direct F1, F8
transaction THC 2021 February Restricted Stock Units Options Exercise $0 -25.2K -50% $0.00 25.2K Mar 6, 2023 Common Stock 25.2K Direct F5, F8
transaction THC 2020 February Restricted Stock Units Options Exercise $0 -48K -100% $0.00* 0 Mar 6, 2023 Common Stock 48K Direct F6, F8
transaction THC 2020 February Performance-Based Restricted Stock Units Options Exercise $0 -57.4K -100% $0.00* 0 Mar 6, 2023 Common Stock 57.4K Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement and vesting of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan.
F4 Represents the closing price of the common stock of the Issuer on the vesting date.
F5 The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023.
F6 The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third and final 1/3 increment settled on March 6, 2023.
F7 On February 26, 2020, the reporting person received a target grant of 35,972 performance-based restricted stock units, scheduled to vest on the third anniversary of the date of grant subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 57,449 units. The performance-based restricted stock units settled on March 6, 2023.
F8 Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock.